Suchergebnisse - "Holtmann, Bettina"

PubPharm (59)

1

USE OF PEGylated IGF-I VARIANTS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS

enthalten in: Europäisches Patentamt | 2018

von HOLTMANN BETTINA | METZGER FRIEDRICH | SENDTNER MICHAEL

2

USE OF PEGYLATED IGF-1 VARIANTS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS

enthalten in: Europäisches Patentamt | 2017

von HOLTMANN BETTINA | METZGER FRIEDRICH | SENDTNER MICHAEL

3

USE OF PEGYLATED IGF-I VARIANTS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS

enthalten in: Europäisches Patentamt | 2016

von HOLTMANN BETTINA | METZGER FRIEDRICH | SENDTNER MICHAEL

4

Use of PEGylated IGF-I Variants For The Treatment Of Neuromuscular Disorders

enthalten in: Europäisches Patentamt | 2015

von HOLTMANN BETTINA | METZGER FRIEDRICH | SENDTNER MICHAEL

5

Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy

enthalten in: Acta neuropathologica | 2015

von Simon, C. | Rauskolb, S. | Gunnersen, J. | +15

6

Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy

enthalten in: Acta neuropathologica | 2015

von Simon, C. | Rauskolb, S. | Gunnersen, J. | +15

7

Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy

enthalten in: Acta neuropathologica | 2015

von Simon, C. | Rauskolb, S. | Gunnersen, J. | +15

8

Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy

enthalten in: Acta neuropathologica | 2015

von Simon, C. | Rauskolb, S. | Gunnersen, J. | +15

9

Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity

enthalten in: Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases | 2012

von Saenger, S. | Holtmann, B. | Nilges, M. | +8

10

Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity

enthalten in: Amyotrophic lateral sclerosis and other motor neuron disorders | 2012

von Saenger, S. | Holtmann, B. | Nilges, M. | +8

1
2
3
4
5
6
Nächster »
[6]